Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Metabolic Syndrome × Triptorelin Pamoate × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 51 Prostate Adenocarcinoma 2 Neoplasms 1 Neoplasm Metastasis 1 Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel 1 Metabolic Syndrome 1 Hypogonadism 1 Fatty Liver 1 Castration-resistant Prostate Cancer Patients with Oligometastases 1

Interventions

Metformin 2 Triptorelin Pamoate 1 Testosterone 1 Orchiectomy 1 Gonadotropin-Releasing Hormone 1 Exercise 1 Diet 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02102646 2015-10-28

MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism

Herlev Hospital

Phase 4 Completed

Fatty Liver, Hypogonadism, Prostatic Neoplasms, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡